Behavioral Scientists have an important role in identifying factors that impact adherence and disease progression in a comprehensive AIDS Research Program. This application requests support for The Behavioral Adherence Retention, and Recruitment (BARR) Core, par of the Health Behavior and Outreach Program in the UCLA Center for AIDS Research. It was developed to provide an infrastructure for behavioral consultation and collaboration within UCLA and with other universities and the community. With the development of new HIV medications and technologies to measure disease progression, multidisciplinary collaborations are needed to address issues including behavioral and medical adherence, access to care, and disease progression. Increasing rates of infection among women and ethnic minority group members, require that diverse populations be included in HIV research, treatment, and clinical trials. Past collaborations between behavioral, basic, and clinical scientists at UCLA have laid the groundwork for this Core. It will provide behavioral science research consultation to students, fellows, faculty and CBOs in areas identified as influencing medical and behavioral adherence in HIV prevention and treatment. The Core will: (a) provide consultation on: psychosocial factors affecting sexual risk reduction, trauma and violence, stress and coping, substance abuse, neuropsychological and psychiatric assessment, acculturation and assimilation, and recruitment and retention of diverse populations; (b) assist in the development of work with all populations affected by the AIDS epidemic; (c) foster University-Wide partnerships among HIV investigators to establish multidisciplinary teams; and (d) provide linkages with studies adherence. The BARR faculty is comprised of researchers with expertise in the areas of Core focus with HIV positive and negative men, women, and children from a variety of ethnic groups. Members of this Core have worked with multidisciplinary teams and have established collaborations with basic science and clinical Cores to ensure integrated research consultation. The mission of this Core within the CFAR is to promote behavioral science HIV/AIDS research at UCLA and the larger Los Angeles community and encourage multidisciplinary and community collaborations in basic, behavioral, and clinical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028697-11
Application #
6324584
Study Section
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
11
Fiscal Year
2000
Total Cost
$142,758
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kiertscher, Sylvia M; Gangalum, Pallavi R; Ibrahim, Grace et al. (2018) A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 13:219-229
Epeldegui, Marta; Magpantay, Larry; Guo, Yu et al. (2018) A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. AIDS 32:945-954
Swendeman, Dallas; Comulada, Warren Scott; Koussa, Maryann et al. (2018) Longitudinal Validity and Reliability of Brief Smartphone Self-Monitoring of Diet, Stress, and Physical Activity in a Diverse Sample of Mothers. JMIR Mhealth Uhealth 6:e176
Swendeman, Dallas; Fehrenbacher, Anne E; Roy, Soma et al. (2018) Gender disparities in depression severity and coping among people living with HIV/AIDS in Kolkata, India. PLoS One 13:e0207055
Beymer, Matthew R; Kofron, Ryan M; Tseng, Chi-Hong et al. (2018) Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County. Int J STD AIDS 29:557-562
Matassoli, Flávio Lemos; Leão, Ihid Carneiro; Bezerra, Bruno Braz et al. (2018) Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation. mSphere 3:
Ramos, Juan C; Sparano, Joseph A; Rudek, Michelle A et al. (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk 18:180-190.e2
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Van, Christina; Condro, Michael C; Lov, Kenny et al. (2018) PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis. J Mol Neurosci :

Showing the most recent 10 out of 942 publications